New approaches under development: Cardiovascular embryology applied to heart disease

Journal of Clinical Investigation

Volumn 123, Issue 1, 2013, Pages 71-74

  Degenhardt, Karl ^a   Singh, Manvendra K ^b   Epstein, Jonathan A ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE INHIBITOR; MICRORNA; MYOSIN HEAVY CHAIN ALPHA; VIRUS VECTOR;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CLINICAL TRIAL (TOPIC); CONGENITAL HEART MALFORMATION; EMBRYOLOGY; FIBROBLAST; GENETIC MANIPULATION; HEART DEVELOPMENT; HEART DISEASE; HEART MUSCLE POTENTIAL; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; NATURAL KILLER T CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATION; REGENERATIVE MEDICINE; REVIEW; SMOOTH MUSCLE FIBER; SOMATIC CELL; TISSUE REGENERATION;

ANIMALS; DIABETES COMPLICATIONS; HEART DISEASES; HUMANS; MYOCARDIUM; OBESITY; PERICARDIUM;

EID: 84873822627     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI62884     Document Type: Review

References (52)

1. Blalock A, Taussig HB. The surgical treatment of malformations of the heart in which there is pulmonary stenosis or pulmonary atresia. JAMA. 1945;128(3): 189-202.
2. Kelly RG, Brown NA, Buckingham ME. The arterial pole of the mouse heart forms from Fgf10- expressing cells in pharyngeal mesoderm. Dev Cell. 2001;1(3): 435-440.
3. Cai CL, et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell. 2003;5(6): 877-889.
4. Epstein JA. Franklin H. Epstein Lecture. Cardiac development and implications for heart disease. N Engl J Med. 2010;363(17): 1638-1647.
5. Parmacek MS, Epstein JA. Cardiomyocyte renewal. N Engl J Med. 2009;361(1): 86-88.
6. Gruber PJ, Epstein JA. Development gone awry: congenital heart disease. Circ Res. 2004;94(3): 273-283.
7. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4): 663-676.
8. Laflamme MA, Murry CE. Heart regeneration. Nature. 2011;473(7347): 326-335.
9. Vieira JM, Riley PR. Chemical genetics and its potential in cardiac stem cell therapy [published online ahead of print March 2, 2012]. Br J Pharmacol. doi:10.1111/j.1476-5381.2012.01928.x.
10. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 1987;51(6): 987-1000.
11. Graf T. Historical origins of transdifferentiation and reprogramming. Cell Stem Cell. 2011;9(6): 504-516.
12. Ieda M, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell. 2011;142(3): 375-386.
13. Qian L, et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature. 2012;485(7400): 593-598.
14. Song K, et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature. 2012;485(7400): 599-604.
15. Chen JX, et al. Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Circ Res. 2012;111(1): 50-55.
16. Boettger T, Braun T. A new level of complexity: the role of microRNAs in cardiovascular development. Circ Res. 2012;110(7): 1000-1013.
17. Small EM, Olson EN. Pervasive roles of microRNAs in cardiovascular biology. Nature. 2011; 469(7330): 336-342.
18. Obad S, et al. Silencing of microRNA families by seedtargeting tiny LNAs. Nat Genet. 2011;43(4): 371-378.
19. Anokye-Danso F, et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell. 2011;8(4): 376-388.
20. Miyoshi N, et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell. 2011;8(6): 633-638.
21. Jayawardena TM, et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res. 2012; 110(11): 1465-1473.
22. Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafish. Science. 2002;298(5601): 2188-2190.
23. Chablais F, Veit J, Rainer G, Jazwinska A. The zebrafish heart regenerates after cryoinjury-induced myocardial infarction. BMC Dev Biol. 2011;11:21.
24. Gonzalez-Rosa JM, Martin V, Peralta M, Torres M, Mercader N. Extensive scar formation and regression during heart regeneration after cryoinjury in zebrafish. Development. 2011;138(9): 1663-1674.
25. Schnabel K, Wu CC, Kurth T, Weidinger G. Regeneration of cryoinjury induced necrotic heart lesions in zebrafish is associated with epicardial activation and cardiomyocyte proliferation. PLoS One. 2011;6(4):e18503.
26. Wang J, et al. The regenerative capacity of zebrafish reverses cardiac failure caused by genetic cardiomyocyte depletion. Development. 2011; 138(16): 3421-3430.
27. Bergmann O, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009;324(5923): 98-102.
28. Porrello ER, et al. Transient regenerative potential of the neonatal mouse heart. Science. 2011; 331(6020): 1078-1080.
29. Lepilina A, et al. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell. 2006;127(3): 607-619.
30. Li D, Epstein JA. Micro-managing myocyte mitosis. Circ Res. 2011;109(6): 611-613.
31. Porrello ER, et al. MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes. Circ Res. 2011;109(6): 670-679.
32. Adzick NS, Thom EA, Spong CY, Brock JW. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011; 364(11): 993-1004.
33. Pavlovic M, Acharya G, Huhta JC. Controversies of fetal cardiac intervention. Early Hum Dev. 2008; 84(3): 149-153.
34. Katz TC, et al. Distinct compartments of the proepicardial organ give rise to coronary vascular endothelial cells. Dev Cell. 2012;22(3): 639-650.
35. Cai CL, et al. A myocardial lineage derives from Tbx18 epicardial cells. Nature. 2008;454(7200): 104-108.
36. Mikawa T, Gourdie RG. Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Dev Biol. 1996;174(2): 221-232.
37. Zhou B, et al. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature. 2008;454(7200): 109-113.
38. van Wijk B, et al. Epicardium and myocardium separate from a common precursor pool by crosstalk between bone morphogenetic protein- and fibroblast growth factor-signaling pathways. Circ Res. 2009;105(5): 431-441.
39. Christoffels VM, Grieskamp T, Norden J, Mommersteeg MT, Rudat C, Kispert A. Tbx18 and the fate of epicardial progenitors. Nature. 2009;458(7240):E8-E9.
40. Smart N, et al. De novo cardiomyocytes from within the activated adult heart after injury. Nature. 2011;474(7353): 640-644.
41. Zhou B, et al. Thymosin beta 4 treatment after myocardial infarction does not reprogram epicardial cells into cardiomyocytes. J Mol Cell Cardiol. 2012;52(1): 43-47.
42. Kispert A. No muscle for a damaged heart: thymosin beta 4 treatment after myocardial infarction does not induce myocardial differentiation of epicardial cells. J Mol Cell Cardiol. 2012;52(1): 10-12.
43. Chong JJ, et al. Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell. 2011;9(6): 527-540.
44. Singh MK, Epstein JA. Epicardium-derived cardiac mesenchymal stem cells: expanding the outer limit of heart repair. Circ Res. 2012;110(7): 904-906.
45. Zhou B, et al. Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. J Clin Invest. 2011;121(5): 1894-1904.
46. Duan J, et al. Wnt1/betacatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair. EMBO J. 2012;31(2): 429-442.
47. Kikuchi K, et al. Retinoic acid production by endocardium and epicardium is an injury response essential for zebrafish heart regeneration. Dev Cell. 2011;20(3): 397-404.
48. Ieda M, et al. Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev Cell. 2009;16(2): 233-244.
49. Chen TH, et al. Epicardial induction of fetal cardiomyocyte proliferation via a retinoic acid-inducible trophic factor. Dev Biol. 2002;250(1): 198-207.
50. Guadix JA, et al. Wt1 controls retinoic acid signalling in embryonic epicardium through transcriptional activation of Raldh2. Development. 2011; 138(6): 1093-1097.
51. Lavine KJ, et al. Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo. Dev Cell. 2005;8(1): 85-95.
52. Tian Y, Morrisey EE. Importance of myocyte-nonmyocyte interactions in cardiac development and disease. Circ Res. 2012;110(7): 1023-1034.